Dalila Masic

Dalila Masic

Auto-generated profile, based on publicly available information

Dalila Masic

Loyola University Medical Center, Maywood, IL, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Journal of Critical Care
Verified
Journal Article
Closed access
DHDaniel Colon Hidalgo
Daniel Colon Hidalgo
JPJaimini Patel
Jaimini Patel
DMDalila Masic
Dalila Masic
DPDavid Park
David Park
MRMegan A. Rech
Megan A. Rech

9 November 2018 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
DMDalila Masic
Dalila Masic
ELEdith Liang
Edith Liang
CLChristina Long
Christina Long
ESEthan J. Sterk
Ethan J. Sterk
BBBrian Barbas
Brian Barbas
MRMegan A. Rech
Megan A. Rech

1 January 2019 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
PDF file
YBYevgeniy Brailovsky
Yevgeniy Brailovsky
VLVladimir Lakhter
Vladimir Lakhter
IWIdo Weinberg
Ido Weinberg
KPKaterina Porcaro
Katerina Porcaro
JHJeremiah Haines
Jeremiah Haines
ADAmir Darki
Amir Darki
Intermediate-risk pulmonary embolism (PE) has variable outcomes. Current risk stratification models lack the positive predictive value to identify patients at highest risk of PE-related mortality. We identified intermediate-risk PE patients who underwent catheter-based interventions and right heart catheterization (RHC) and identified those with low cardiac index (CI < 2.2 L/min/m2). We utilized regression models to identify echocardiographic predictors of low CI and Kaplan Meier curve to evaluate PE-related mortality when stratified by the echocardiographic predictor. Of 174 intermediate-risk PE patients, 41 underwent RHC. Within this cohort, 46.3% had low CI. Univariable linear regression identified right ventricular outflow tract velocity time integral (RVOT VTI), right/left ventricular ratio, S prime, inferior vena cava diameter, and pulmonary artery systolic pressure as potential predictors of low CI. Multivariable linear regression identified RVOT VTI as significant predictor of low CI (β coefficient 0.124, 95% confidence interval [CI]: 0.01-0.24, P = .034). Right ventricular outflow tract velocity time integral <9.5 cm was associated with increased PE-related mortality, P = .002. A substantial proportion of intermediate-risk PE patients referred for catheter-based interventions had low CI despite normotension. Right ventricular outflow tract velocity time integral was a significant predictor of low CI. Low RVOT VTI was associated with increased PE-related mortality.

1 November 2019 in The Journal of Emergency Medicine
Verified
Journal Article
Closed access
DMDalila Masic
Dalila Masic
DHDaniel Colon Hidalgo
Daniel Colon Hidalgo
SKShannon Kuhrau
Shannon Kuhrau
WCWhitney Chaney
Whitney Chaney
MRMegan A. Rech
Megan A. Rech

8 August 2019 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
YBYevgeniy Brailovsky
Yevgeniy Brailovsky
SKSiri Kunchakarra
Siri Kunchakarra
VLVladimir Lakhter
Vladimir Lakhter
GBGeoffrey Barnes
Geoffrey Barnes
DMDalila Masic
Dalila Masic
ADAmir Darki
Amir Darki

1 July 2020 in JACC: Case Reports
Verified
Journal Article
Open access
AMAlexandru Marginean
Alexandru Marginean
DMDalila Masic
Dalila Masic
YBYevgeniy Brailovsky
Yevgeniy Brailovsky
JFJawed Fareed
Jawed Fareed
ADAmir Darki
Amir Darki
Acute pulmonary embolism (PE) is a potentially life-threatening manifestation of venous thromboembolic disease. Severe acute respiratory syndrome-coronavirus-2, a novel coronavirus that causes coronavirus disease-2019 (COVID-19), has been associated with an increased risk of thrombosis. We describe the therapeutic challenges of 3 patients presenting with PE and suspected or confirmed COVID-19. (Level of Difficulty: Beginner.)